Subject Matter Expertise, Training, and Technical Assistance

Notice of Funding Opportunity: A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes—Subject Matter Expertise, Training, and Technical Assistance: CDC-RFA-DP23-0021 Notice of Funding Opportunity

Deadline for Applications: March 14, 2023, electronically submitted applications must be submitted no later than 11:59 pm EST on the listed application due date.

Purpose/Summary

The Centers for Disease Control and Prevention (CDC) announces the availability of funds for notice of funding opportunity (NOFO) DP-23-0021—A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes—Subject Matter Expertise, Training, and Technical Assistance.  This NOFO seeks to support the goals and objectives of the companion NOFO, CDC-RFA-DP23-0020: A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes, which seeks to prevent or delay onset of type 2 diabetes among adults with prediabetes; improve self-care practices, quality of care, and early detection of complications among people with diabetes; and support implementation of evidence-based, family-centered childhood obesity interventions as a type 2 diabetes risk reduction strategy. All work supported under this NOFO aims to increase capacity among the companion NOFO recipients to improve equitable access to and delivery of diabetes management and type 2 diabetes prevention and risk reduction interventions for priority populations, defined as those who have systematically experienced greater obstacles to health based on their racial or ethnic group; religion; socioeconomic status; gender; age; mental health; cognitive, sensory, or physical disability; sexual orientation or gender identity; geographic location; or other characteristics historically linked to discrimination or exclusion. Successful applicants will ensure companion NOFO recipients have relevant knowledge and skills by 1) obtaining and providing subject matter expertise through a network of sustainable partnerships, 2) providing training and technical assistance (TA), and 3) developing guidance documents and resources that inform their work.

Eligibility

Applicant eligibility is unrestricted and open to any organization that meets the NOFO requirements. Please refer to Section C of the NOFO for information on eligibility. http://www.hhs.gov/sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf.

Funding

DP-23-0021 is supported by the Division of Diabetes Translation in the National Center for Chronic Disease Prevention and Health Promotion at CDC. In FY 2023, $10,000,000 is anticipated to be awarded for Year 1 activities beginning June 2023. One applicant will be funded to complete activities covering the three strategies described in the NOFO.

The total projected estimated funding for the entire 5-year project period is $50,000,000.

Strategies and Activities

Applicants are required to describe the approach they will take to address the following three strategies:

Strategy 1: Obtain and provide subject matter expertise through a network of partners and subject matter experts to ensure companion NOFO recipients have relevant knowledge and skills to implement evidence-based approaches for diabetes management and type 2 diabetes prevention and risk reduction in priority populations. Please refer to DP- 23-0021 NOFO for a complete description of required subject matter expertise.

Strategy 2: Provide training and technical assistance (TA) to ensure relevant knowledge and skills of the companion NOFO recipients to implement evidence-based approaches to diabetes management and type 2 diabetes prevention and risk reduction in priority populations.

• In consultation with CDC, applicants will be responsible for: 1) conducting a rapid assessment of companion NOFO recipients to identify training and TA needs; 2) developing a training and TA plan that includes peer learning; 3) establishing communities of practice and/or learning collaboratives to facilitate information sharing and peer learning; 4) designing, implementing, and facilitating a minimum of two meetings for companion NOFO recipients, including an initial orientation meeting in year 1; 5) developing, promoting, delivering, and facilitating training and TA; and 6) evaluating the delivery of training, TA, and peer learning activities.

Strategy 3: Develop guidance documents and resources for the companion NOFO recipients to ensure relevant knowledge and skills to implement evidence-based approaches to diabetes management and type 2 diabetes prevention and risk reduction in priority populations.

• In consultation with CDC, applicants will be responsible for developing: 1) well-written and technically accurate guidance documents to support recipients’ understanding and implementation of the companion NOFO strategies; 2) a standard interactive orientation package for new recipient staff; 3) resources to demonstrate the value of program activities and showcase recipients’ progress, success, capacity, and outcomes (e.g., success stories, summation of lessons learned, impact briefs, reports, newsletters, websites, etc.); and 4) materials to support the evaluation of program activities and identify and document promising practices (e.g., case studies, emerging practice examples, etc.).

Prospective applicants should read the published NOFO (and the companion NOFO) in detail for a full description of the strategies and related requirements.

Informational Conference Call

CDC will hold an informational call on January 20, 2023, 3:00 PM Eastern Standard Time (EST) for organizations interested in submitting an application.

Letter of Intent

A letter of intent (LOI) should be sent by January 27, 2023, via email to DP2321TA@cdc.gov. The purpose of a Letter of Intent (LOI) is to allow CDC to estimate the number of and plan for the review of submitted applications.  LOIs are not required as part of the application for this NOFO. Non-submission will not impact the review of applications.  Please refer to the NOFO for the information that should be included in the LOI.